Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences

INTRODUCTION: While Alzheimer’s disease (AD) is divided into severity stages, mild cognitive impairment (MCI) remains a solitary construct despite clinical and prognostic heterogeneity. This study aimed to characterize differences in genetic, cerebrospinal fluid (CSF), neuroimaging, and neuropsychol...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Elizabeth E., Liu, Dandan, Pechman, Kimberly R., Acosta, Lealani Mae Y., Bell, Susan P., Davis, L. Taylor, Blennow, Kaj, Zetterberg, Henrik, Landman, Bennett A., Schrag, Matthew S., Hohman, Timothy J., Gifford, Katherine A., Jefferson, Angela L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289958/
https://www.ncbi.nlm.nih.gov/pubmed/32581762
http://dx.doi.org/10.3389/fnagi.2020.00139

Ejemplares similares

Ejemplares similares